Dow Jones
39.452,24 -60,60 (-0,15%) Nasdaq
16.388,03 +47,16 (+0,29%) Nikkei 225
38.179,46 -49,65 (-0,13%) EUR/USD
1,0796 +0,0023 (+0,22%) Bitcoin EUR
58.507,41 +1.776,43 (+3,13%) CMC Crypto 200
1.298,90 +38,69 (+3,07%)
OptimizeRx Corporation (OPRX)
| Chiusura precedente | 10,81 |
| Aperto | 10,94 |
| Denaro | 10,38 x 100 |
| Lettera | 10,48 x 100 |
| Min-Max giorno | 10,34 - 10,99 |
| Intervallo di 52 settimane | 6,92 - 16,65 |
| Volume | |
| Media Volume | 136.680 |
| Capitalizzazione | 189,113M |
| Beta (5 anni mensile) | 1,05 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -1,03 |
| Prossima data utili | 14 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 16,17 |
GlobeNewswireOptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers
Preannounces Preliminary Third Quarter 2023 Results OptimizeRx adds new, proven, profitable technologies to become the most comprehensive healthcare marketing platform in the nation. Consolidated revenue run rate will increase to nearly $100 million and the acquisition is expected to be immediately accretive to earnings. Third quarter 2023 headline numbers to come in ahead of consensus with revenue for OptimizeRx standalone expected to be between $15.2-$15.5 million and non-GAAP net income expec
- GlobeNewswire
OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform
The New AI-Directed Capability Unites Point-of-Care and Traditional Digital Medias to Provide a Comprehensive Solution for Pharmaceutical MarketingWALTHAM, Mass., Sept. 26, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced a new artificial intelligence (AI) solution, transforming its HCP engagement platform. T
- GlobeNewswire
OptimizeRx Expands AI Powered Omnichannel Platform
WALTHAM, Mass., Aug. 24, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced the expansion of its AI-enabled healthcare technology platform’s reach through multi-year partnerships with two leading electronic health record (EHR) providers and a telehealth platform. These partnerships are expected to be active within the platform later this year and to material
